|
RAC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.991500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.835800E-03 |
| Normal-vs-Stage2 |
2.884000E-01 |
| Normal-vs-Stage3 |
5.118400E-02 |
| Normal-vs-Stage4 |
3.84989999999696E-05 |
| Stage1-vs-Stage2 |
5.071600E-01 |
| Stage1-vs-Stage3 |
5.499400E-01 |
| Stage1-vs-Stage4 |
1.300250E-02 |
| Stage2-vs-Stage3 |
7.688600E-01 |
| Stage2-vs-Stage4 |
3.707600E-02 |
| Stage3-vs-Stage4 |
1.628450E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.231100E-04 |
| Normal-vs-AfricanAmerican |
8.494000E-01 |
| Normal-vs-Asian |
3.015400E-01 |
| Caucasian-vs-AfricanAmerican |
1.413660E-02 |
| Caucasian-vs-Asian |
6.572200E-01 |
| AfricanAmerican-vs-Asian |
3.245800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.681730E-03 |
| Normal-vs-Female |
5.559200E-03 |
| Male-vs-Female |
9.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.196400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.836000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.396600E-03 |
| Normal-vs-Age(81-100Yrs) |
3.166000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.106600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.623600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.466100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.035800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.404210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.409900E-02 |
| Normal-vs-Grade 2 |
1.446930E-04 |
| Normal-vs-Grade 3 |
6.006000E-02 |
| Normal-vs-Grade 4 |
8.122200E-03 |
| Grade 1-vs-Grade 2 |
9.106200E-01 |
| Grade 1-vs-Grade 3 |
2.874400E-01 |
| Grade 1-vs-Grade 4 |
9.133800E-01 |
| Grade 2-vs-Grade 3 |
1.413560E-02 |
| Grade 2-vs-Grade 4 |
9.743000E-01 |
| Grade 3-vs-Grade 4 |
1.408180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.279780E-03 |
| Normal-vs-ccB subtype |
1.086440E-02 |
| ccA subtype-vs-ccB subtype |
5.566000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.903790E-03 |
| Normal-vs-N1 |
5.109900E-02 |
| N0-vs-N1 |
1.437650E-01 |
|
|
